|
|
|
|
No Evidence of 1-Year Reinfection after Treating HCV at a Methadone Program
|
|
|
Reported by Jules Levin
AASLD Annual Meeting 2017, Washington, DC, USA, October 20-24
Diana L. Sylvestre, MD1,2; Yvonne Malibu2; and Cara Eberhardt21University of CA, San Francisco, 2OASIS Clinic, Oakland, CA
Support was received from Abbvie for the conduct of this study.
|
|
|
|
|
|
|